Reuters logo
BRIEF-Probiodrug Q1 comprehensive loss widens to 2.8 million euros
May 12, 2017 / 5:13 AM / 6 months ago

BRIEF-Probiodrug Q1 comprehensive loss widens to 2.8 million euros

May 12 (Reuters) - PROBIODRUG AG:

* PROBIODRUG AG REPORTS FIRST QUARTER 2017 BUSINESS UPDATE

* Q1 OF 2017 SHOWED AN INCREASE OF RESEARCH AND DEVELOPMENT EXPENSES TO EUR 2,268K COMPARED TO EUR 1,974K IN Q1 OF 2016

* Q1 COMPREHENSIVE LOSS OF THE REPORTING PERIOD WAS EUR 2,798K, COMPARED TO EUR 2,596K IN THE FIRST QUARTER OF 2016

* PROBIODRUG HELD EUR 18.7 MILLION IN CASH AND CASH EQUIVALENTS AS OF 31 MARCH 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below